Mesenchymal Stem Cells Show Promise in Preclinical Studies of MS

Mesenchymal Stem Cells Show Promise in Preclinical Studies of MS

307309

Mesenchymal Stem Cells Show Promise in Preclinical Studies of MS

The therapeutic administration of mesenchymal stem cells can improve functional abilities and promote the restoration of lost myelin in rodent models of multiple sclerosis (MS), according to a new analysis of published studies. The findings highlight the potential of these stem cells, but also point to a need for more research on how best to use them as a treatment. Results were published in Frontiers in Immunology, in the study “The Efficacy of Mesenchymal Stem Cell…

You must be logged in to read/download the full post.